Lexington, MA-based Quanterix has developed the Simoa platform, which performs extremely sensitive automated detection and quantification of protein biomarkers. This includes blood biomarkers related to brain injury.
Quanterix was recognized as one of six final winners in the Head Health Challenge I, sponsored by the NFL and GE, for its efforts to speed diagnosis of mild traumatic brain injuries.
[Image courtesy of QUANTERIX]
|Learn about "Tapping the Explosion of Offerings in Sensors" at the MD&M Minneapolis Conference, September 21-22.|